Liberum Capital restated their buy rating on shares of Assura PLC (LON:AGR) in a research report released on Tuesday morning. Liberum Capital currently has a GBX 68 ($0.90) price objective on the real estate investment trust’s stock.

Separately, Peel Hunt reiterated a hold rating and set a GBX 55 ($0.73) price objective on shares of Assura PLC in a research report on Tuesday, June 20th.

Shares of Assura PLC (LON AGR) opened at 63.55 on Tuesday. Assura PLC has a 12-month low of GBX 51.35 and a 12-month high of GBX 65.00. The stock’s 50 day moving average price is GBX 63.34 and its 200 day moving average price is GBX 59.87. The firm’s market cap is GBX 1.05 billion.

ILLEGAL ACTIVITY WARNING: “Assura PLC (AGR) Rating Reiterated by Liberum Capital” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at

The company also recently disclosed a dividend, which was paid on Wednesday, July 19th. Shareholders of record on Thursday, June 15th were given a dividend of GBX 0.60 ($0.01) per share. This represents a yield of 1.01%. The ex-dividend date was Thursday, June 15th.

About Assura PLC

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.

Receive News & Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related companies with's FREE daily email newsletter.